Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2928

Actual shortage: 212 (7%)
Anticipated shortage: 0 (0%)
Avoided shortage: 10 (0%)
Resolved: 2706 (92%)

Discontinuation Reports

299

To be discontinued: 2 (1%)
Discontinued: 297 (99%)
Reversed: 0 (0%)

Late reports

361 (11%)

Overdue reports

85 (40%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
AMPICILLIN SODIUM FOR INJECTION, USP 500MG POWDER FOR SOLUTION Resolved 2022-03-31 2022-12-20 157650
AMPICILLIN SODIUM FOR INJECTION, USP 500MG POWDER FOR SOLUTION Resolved 2022-04-28 2023-01-19 159584
AMPICILLIN SODIUM FOR INJECTION, USP 2G POWDER FOR SOLUTION Resolved 2022-06-16 2023-04-28 162846
AMPICILLIN SODIUM FOR INJECTION, USP 500MG POWDER FOR SOLUTION Resolved 2020-11-06 2021-03-18 128031
AMPICILLIN SODIUM FOR INJECTION, USP 1000MG POWDER FOR SOLUTION Resolved 2019-06-18 2019-09-19 86939
AMPICILLIN SODIUM FOR INJECTION, USP 2000MG POWDER FOR SOLUTION Resolved 2019-06-18 2019-09-19 86942
AMPICILLIN SODIUM FOR INJECTION, USP 500MG POWDER FOR SOLUTION Resolved 2019-06-27 2019-11-07 87653
AMPICILLIN SODIUM FOR INJECTION, USP 1G POWDER FOR SOLUTION Resolved 2021-05-27 2021-08-06 140036
AMPICILLIN SODIUM FOR INJECTION, USP 1G POWDER FOR SOLUTION Resolved 2021-06-03 2021-08-05 140369
AMPICILLIN SODIUM FOR INJECTION, USP 250MG POWDER FOR SOLUTION Resolved 2019-09-05 2019-09-19 93110
AMPICILLIN SODIUM FOR INJECTION, USP 250MG POWDER FOR SOLUTION Actual shortage 2025-04-04 2025-04-24 254136
AMPICILLIN SODIUM FOR INJECTION, USP 2G POWDER FOR SOLUTION Resolved 2021-07-08 2021-08-24 142189
AMPICILLIN SODIUM FOR INJECTION, USP 500MG POWDER FOR SOLUTION Resolved 2021-08-13 2021-10-07 144105
AMPICILLIN SODIUM FOR INJECTION, USP 250MG POWDER FOR SOLUTION Resolved 2021-10-28 2021-11-25 148421
AMPICILLIN SODIUM FOR INJECTION, USP 1G POWDER FOR SOLUTION Resolved 2022-01-27 2022-12-20 153739
APRI 21 0.03MG 0.15MG TABLET Resolved 2022-10-28 2022-12-02 173067
APRI 21 0.15MG 0.03MG TABLET Resolved 2017-05-23 2017-09-19 10868
APRI 28 0.15MG 0.03MG TABLET Resolved 2017-05-23 2017-09-19 10871
APRI 28 0.03MG 0.15MG TABLET Resolved 2022-10-28 2022-12-02 173064
APRI 28 0.15MG 0.03MG TABLET Resolved 2019-08-29 2019-10-24 92660

Showing 301 to 320 of 2928

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-DEFERASIROX 250MG TABLET FOR SUSPENSION Discontinued 2020-01-21 2020-01-21 103796
TEVA-DICLOFENAC EC 50MG TABLET (ENTERIC-COATED) Discontinued 2025-03-20 2025-03-20 253156
TEVA-DICLOFENAC EC 25MG TABLET (ENTERIC-COATED) Discontinued 2024-01-25 2024-01-26 217254
TEVA-DICLOFENAC EC 50MG TABLET (ENTERIC-COATED) Discontinued 2025-04-25 2025-04-25 255812
TEVA-DICLOFENAC SR 75MG TABLET (EXTENDED-RELEASE) Discontinued 2025-04-29 2025-04-29 256131
TEVA-DICLOFENAC-K 50MG TABLET Discontinued 2025-03-20 2025-03-20 253168
TEVA-DILTIAZEM CD 240MG CAPSULE (EXTENDED RELEASE) Discontinued 2019-04-11 2019-04-11 81307
TEVA-DILTIAZEM CD 180MG CAPSULE (EXTENDED RELEASE) Discontinued 2019-06-04 2019-06-04 85572
TEVA-DILTIAZEM CD 120MG CAPSULE (EXTENDED RELEASE) Discontinued 2019-06-04 2019-06-04 85575
TEVA-DIVALPROEX 125MG TABLET (ENTERIC-COATED) Discontinued 2019-10-25 2019-10-26 97232
TEVA-DIVALPROEX 250MG TABLET (ENTERIC-COATED) Discontinued 2019-10-25 2019-10-26 97235
TEVA-DIVALPROEX 500MG TABLET (ENTERIC-COATED) Discontinued 2019-10-25 2019-10-26 97238
TEVA-DULOXETINE 30MG CAPSULE (DELAYED RELEASE) Discontinued 2020-06-11 2020-06-11 117491
TEVA-DULOXETINE 60MG CAPSULE (DELAYED RELEASE) Discontinued 2020-06-11 2020-06-11 117494
TEVA-ECTOSONE 0.1% LOTION Discontinued 2023-12-05 2023-12-05 212526
TEVA-EFAVIRENZ 600MG TABLET Discontinued 2025-04-29 2025-04-29 256134
TEVA-ENALAPRIL 8MG TABLET Discontinued 2018-10-19 2018-10-19 64855
TEVA-ENALAPRIL 8MG TABLET Discontinued 2018-10-19 2018-10-19 64858
TEVA-ENALAPRIL 8MG TABLET Discontinued 2018-10-19 2018-10-19 64861
TEVA-ENALAPRIL 16MG TABLET Discontinued 2018-10-19 2018-10-19 64866

Showing 161 to 180 of 299